Restorative Dentistry Notes on Peri-Implant Diseases and Management Strategies

Abstract

  • Overview of the commonality of peri-implant disease among dental implant patients.
  • Highlights preventive and supportive regimens as best practices, yet acknowledges treatment challenges.
  • Discusses treatment options including non-surgical and surgical approaches for peri-implant mucositis and peri-implantitis.

Authors and Institution

  • Alex Daly, BDS, FHEA, MClinDent: Specialty Registrar in Restorative Dentistry.
  • Giles McCracken, BDS, PhD, FDS(Rest Dent) RCPS, FHEA: Professor of Restorative Dentistry.
  • Affiliation: School of Dental Sciences, Newcastle University, Newcastle, UK.

Peri-Implant Diseases: Definitions and Prevalence

  • Polymicrobial, biofilm-associated inflammatory lesions: Nature of peri-implant diseases.
  • Peri-implant mucositis: Inflammation of peri-implant tissues with no associated bone loss. A precursor to peri-implantitis.
  • Peri-implantitis: Characterized by loss of supporting clinical attachment and bone.
  • Prevalence Statistics:
    • Peri-implantitis: Affects approx. 10% of implants, 20% of patients over a minimum of 5 years.
    • Range: 6.6% to 36.6% of implants; 11.2% to 47.1% of patients.
    • Peri-implant mucositis: Approximately 50% of implants, nearly 80% of patients.

Management of Peri-Implant Disease

Supportive Therapy

  • Post-implant placement: Enroll patients in a supportive maintenance program for regular reviews to manage inflammatory lesions.
  • Importance of regular supportive care for:
    • Early detection and management of peri-implant diseases.
    • Statistical evidence: Incidence of peri-implantitis lower in individuals with regular maintenance (18%) versus no maintenance (43.9%).
  • Assessment Parameters:
    • Signs/symptoms of inflammation/disease, plaque scores, pocket depths, bleeding indices, mobility, presence of suppuration, assessment of crestal bone levels via radiographs.
  • Risk factors assessment:
    • Poor plaque control, periodontal history, uncontrolled diabetes, smoking status.
  • Frequency of recall visits typically varies (3, 6, or 12 months) based on perceived risk of peri-implant disease.

Peri-Implant Mucositis Management

  • Defined as an inflammation without loss of bone; acts as a preventive step against peri-implantitis.
  • Management strategies include:
    • Enhancing daily oral hygiene practices tailored to patient needs.
    • Modifying/removing local factors (excess cement, bulky prostheses) hindering hygiene.
  • Mechanical Decontamination:
    • Removal of hard/soft tissue deposits from contaminated implant surfaces.
    • Identification of specific characteristics for implants vs natural gingival sulcus affecting decontamination methods.
    • Suggested tools:
    • Supramucosal: Pumice slurry and polishing cups for plaque removal.
    • Submucosal: Titanium scalers or ultrasonic devices; metal devices must be softer than titanium to prevent damage.
  • Adjunct treatments:
    • Local/systemic antibiotics or chlorhexidine show minimal significant impact on long-term treatment outcomes.
    • Alternative decontamination methods (air-abrasive devices, lasers) lack long-term evidence.

Peri-Implantitis Management: Non-Surgical

  • Non-surgical therapy can reduce inflammation and allows assessment of tissue healing and patient hygiene effectiveness.
  • Efficacy can be modest; challenging due to:
    • Implant thread geometry and roughness complicating decontamination.
    • Resistance of gram-negative anaerobic microbiota akin to severe periodontitis.

Peri-Implantitis Management: Surgical

  • Surgical options may yield more predictable outcomes:
    • Improve access for thorough decontamination.
    • Enable pocket elimination through resective procedures or regeneration opportunities.
  • Flap Procedures:
    • Access Flap: Aims to decontaminate the implant while retaining soft tissue height; minimal bone loss conditions.
    • Apically Repositioned Flap: Used in areas without aesthetic concerns; focuses on reducing pocket depth and improving oral hygiene access.
    • Methods involve:
    • Inverse bevel incision for elevation and maintenance of soft tissue height.
Implant Surface Decontamination
  • Post-debridement requires decontamination for re-osseointegration.
  • Various agents have been suggested (saline, citric acid, laser), yet no single superior method has been established.
Regeneration Procedures
  • Aim to modify tissue response and avoid recession during healing.
  • Success relies on complete mechanical and chemical decontamination.
  • Graft options include autologous, xenograft, or bone substitutes, covered with membranes to promote healing.
  • Factors determining graft procedure success include defect nature (intrabony vs. suprabony).

Antibiotics and Surgical Outcomes

  • Mechanical interventions significantly reduce inflammation. The impact of systemic antibiotics long-term is uncertain due to possible resistance.

Success Measurement

  • Absence of bleeding/suppuration during follow-ups highly indicative of reduced future bone loss.
  • Some patients may require additional treatments or implant removal depending on disease progression.

Treatment Protocols

  • “Treatment Ladder” Approach:
    • Evolving from plaque control modifications, non-surgical therapy, through to surgical interventions.
    • Complexity increases with treatment stages; initial success may influence future management strategy.
    • Evidence for a specific comprehensive protocol is limited, yet a staged approach is logical.

Summary of Peri-Implant Diseases

  • Common inflammatory conditions affecting tissues surrounding dental implants.
  • Risk factors, non-surgical treatments, and surgical options cater to managing peri-implantitis determined by defect nature.
  • Focus on patient engagement, ongoing support, and regular monitoring crucial for long-term success.